Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial.

Mori AT, Kampata L, Musonda P, Johansson KA, Robberstad B, Sandøy I.

Trials. 2017 Dec 19;18(1):604. doi: 10.1186/s13063-017-2350-4.

2.

Economic burden of malaria and predictors of cost variability to rural households in south-central Ethiopia.

Hailu A, Lindtjørn B, Deressa W, Gari T, Loha E, Robberstad B.

PLoS One. 2017 Oct 11;12(10):e0185315. doi: 10.1371/journal.pone.0185315. eCollection 2017.

3.

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework.

Jull J, Whitehead M, Petticrew M, Kristjansson E, Gough D, Petkovic J, Volmink J, Weijer C, Taljaard M, Edwards S, Mbuagbaw L, Cookson R, McGowan J, Lyddiatt A, Boyer Y, Cuervo LG, Armstrong R, White H, Yoganathan M, Pantoja T, Shea B, Pottie K, Norheim O, Baird S, Robberstad B, Sommerfelt H, Asada Y, Wells G, Tugwell P, Welch V.

BMJ Open. 2017 Sep 25;7(9):e015815. doi: 10.1136/bmjopen-2016-015815.

4.

Household costs and time to seek care for pregnancy related complications: The role of results-based financing.

Chinkhumba J, De Allegri M, Mazalale J, Brenner S, Mathanga D, Muula AS, Robberstad B.

PLoS One. 2017 Sep 21;12(9):e0182326. doi: 10.1371/journal.pone.0182326. eCollection 2017.

5.

Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania.

Ngalesoni F, Ruhago G, Mayige M, Oliveira TC, Robberstad B, Norheim OF, Higashi H.

PLoS One. 2017 Aug 2;12(8):e0182113. doi: 10.1371/journal.pone.0182113. eCollection 2017.

6.

Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.

Nankabirwa V, Tumwine JK, Namugga O, Tylleskär T, Ndeezi G, Robberstad B, Netea MG, Sommerfelt H.

Trials. 2017 Mar 31;18(1):152. doi: 10.1186/s13063-017-1881-z.

7.

Explaining changes in child health inequality in the run up to the 2015 Millennium Development Goals (MDGs): The case of Zambia.

Hangoma P, Aakvik A, Robberstad B.

PLoS One. 2017 Feb 7;12(2):e0170995. doi: 10.1371/journal.pone.0170995. eCollection 2017.

8.

Equity impact analysis of medical approaches to cardiovascular diseases prevention in Tanzania.

Ngalesoni FN, Ruhago GM, Mori AT, Robberstad B, Norheim OF.

Soc Sci Med. 2016 Dec;170:208-217. doi: 10.1016/j.socscimed.2016.08.033. Epub 2016 Aug 24.

9.

Equity in long-lasting insecticidal nets and indoor residual spraying for malaria prevention in a rural South Central Ethiopia.

Hailu A, Lindtjørn B, Deressa W, Gari T, Loha E, Robberstad B.

Malar J. 2016 Jul 16;15:366. doi: 10.1186/s12936-016-1425-0.

10.

Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.

Ngalesoni FN, Ruhago GM, Mori AT, Robberstad B, Norheim OF.

BMC Health Serv Res. 2016 May 17;16:185. doi: 10.1186/s12913-016-1409-3.

11.

Malaria incidence and entomological findings in an area targeted for a cluster-randomized controlled trial to prevent malaria in Ethiopia: results from a pilot study.

Gari T, Kenea O, Loha E, Deressa W, Hailu A, Balkew M, Gebre-Michael T, Robberstad B, Overgaard HJ, Lindtjørn B.

Malar J. 2016 Mar 8;15:145. doi: 10.1186/s12936-016-1199-4.

12.

Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: study protocol for a cluster randomized controlled trial.

Deressa W, Loha E, Balkew M, Hailu A, Gari T, Kenea O, Overgaard HJ, Gebremichael T, Robberstad B, Lindtjørn B.

Trials. 2016 Jan 12;17:20. doi: 10.1186/s13063-016-1154-2.

13.

Cost-Effectiveness of Peer Counselling for the Promotion of Exclusive Breastfeeding in Uganda.

Chola L, Fadnes LT, Engebretsen IM, Nkonki L, Nankabirwa V, Sommerfelt H, Tumwine JK, Tylleskar T, Robberstad B; PROMISE-EBF Study Group.

PLoS One. 2015 Nov 30;10(11):e0142718. doi: 10.1371/journal.pone.0142718. eCollection 2015.

14.

Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.

Mori AT, Norheim OF, Robberstad B.

Pharmacoeconomics. 2016 Mar;34(3):303-14. doi: 10.1007/s40273-015-0344-1.

15.

[B. Robberstad replies].

Robberstad B.

Tidsskr Nor Laegeforen. 2015 Sep 22;135(17):1530. doi: 10.4045/tidsskr.15.0910. eCollection 2015 Sep 22. Norwegian. No abstract available.

16.

[Re: Markov modeling].

Wisløff T, Robberstad B.

Tidsskr Nor Laegeforen. 2015 Sep 8;135(16):1432. doi: 10.4045/tidsskr.15.0837. eCollection 2015 Sep 8. Norwegian. No abstract available.

17.

Age and severity.

Robberstad B.

Tidsskr Nor Laegeforen. 2015 Aug 25;135(15):1376-8. doi: 10.4045/tidsskr.15.0389. eCollection 2015 Aug 25. English, Norwegian. No abstract available.

18.

Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania.

Ruhago GM, Ngalesoni FN, Robberstad B, Norheim OF.

Cost Eff Resour Alloc. 2015 Apr 28;13:7. doi: 10.1186/s12962-015-0033-0. eCollection 2015.

19.

Factors associated with delivery outside a health facility: cross-sectional study in rural Malawi.

Mazalale J, Kambala C, Brenner S, Chinkhumba J, Lohmann J, Mathanga DP, Robberstad B, Muula AS, De Allegri M.

Trop Med Int Health. 2015 May;20(5):617-626. doi: 10.1111/tmi.12473. Epub 2015 Mar 2.

20.

Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: a meta-analysis of population-based cohort studies.

Chinkhumba J, De Allegri M, Muula AS, Robberstad B.

BMC Public Health. 2014 Sep 28;14:1014. doi: 10.1186/1471-2458-14-1014.

Supplemental Content

Loading ...
Support Center